Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lunai Bioworks Inc.
Report date April 15, 2022 · Filed August 03, 2022
Section 16 reporting ended · disclosed 2022-08-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectN/A | 3,456,831 |
Reported balance
After 2022-04-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-04-15 · Other · Disposed 3,969,090 · Balance 3,456,831 F1: By Weird Science, LLC |
| Common StockSEC Table I · non-derivative | Direct | 4,449,104 |
Reported balance
After 2022-04-15 transaction · row 2
1 source rowRow 2 · 2022-04-15 · Other · Acquired 992,273 · Balance 4,449,104 |
Filing footnotes · ownership attribution and instrument terms
F1: By Weird Science, LLC
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2022 Filed Aug 3, 2022 09:16 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 992,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001085146-22-002743 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Former director see note below 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449,104 Read SEC document |
| April 15, 2022 Filed Aug 3, 2022 09:16 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 3,969,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001085146-22-002743 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Former director see note below 10b5-1 filing: Not disclosed Ownership: Indirect · N/A Disclosed balance after: 3,456,831 F1 · ownership.direct: By Weird Science, LLC Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 16:30 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | SaleCommon Stock | 1,927 | $9.06 | $17,458.62 |
DisclosureSEC source: 0001731122-22-000522 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,187,487 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 17:18 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | SaleCommon Stock | 6 | $9.00 | $54.00 |
DisclosureSEC source: 0001731122-22-000303 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,414 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 17:18 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | SaleCommon Stock | 6,792 | $9.03 | $61,348.06 |
DisclosureSEC source: 0001731122-22-000303 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,420 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021. Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 3 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,196,212 Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 2 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,197,712 Read SEC document |
| December 28, 2021 Filed Jan 7, 2022 18:32 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-22-000033 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199,212 Read SEC document |
| February 28, 2021 Filed Dec 22, 2021 11:18 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 12,712 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001731122-21-002178 · ownership.xml · derivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,712 Underlying: Common stock · 12,712 shares Expires 2031-02-28 F1 · shares: On February 28, 2021, Mr. Sandler was granted an option to purchase 12,712 shares of common stock of Enochian Biosciences Inc., said option to vest on February 28, 2022. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 14:00 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 61,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-20-001303 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner William Anderson Wittekind · CIK 0001753085 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Weird Science, LLC Disclosed balance after: 4,961,363 F1 · security: On December 14, 2020, Weird Science, LLC received 61,249 shares of common stock pursuant to a contractual right to receive shares upon the exercise of outstanding warrants of the Issuer. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 18:55 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 8,248 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001731122-19-000522 · ownership.xml · derivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,248 Underlying: Common stock · 8,248 shares Expires 2029-02-25 Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 21:28 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 3,631,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-19-000425 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner William Anderson Wittekind · CIK 0001753085 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Weird Science, LLC Disclosed balance after: 22,445,397 F1 · security: On July 30, 2019, Weird Science, LLC received 3,631,234 shares of common stock pursuant to a contractual right to receive shares upon the exercise of warrants by warrant holders of the Issuer. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:43 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | OtherCommon Stock | 1,268,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-19-000007 · ownership.xml · nonDerivative · entry 1 Sandler Carl Forest Jr · CIK 0001734560 · Director · 10% owner William Anderson Wittekind · CIK 0001753085 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Weird Science, LLC Disclosed balance after: 18,814,163 F1 · security: On December 31, 2018, Weird Science, LLC received 1,268,880 shares of common stock pursuant to a contractual right to receive shares upon the exercise of warrants by RS Bio ApS. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.